Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction - ScienceDirect

By A Mystery Man Writer

2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino

C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial Infarction - Journal of Cardiac Failure

CineCT platform for in vivo and ex vivo measurement of 3D high resolution Lagrangian strains in the left ventricle following myocardial infarction and intramyocardial delivery of theranostic hydrogel - Journal of Molecular

SciELO - Brasil - Independent Predictors of Late Presentation in Patients with ST-Segment Elevation Myocardial Infarction Independent Predictors of Late Presentation in Patients with ST-Segment Elevation Myocardial Infarction

Pulse Oximetry in the Diagnosis of Acute Heart Failure

The global prevalence of myocardial infarction: a systematic review and meta-analysis, BMC Cardiovascular Disorders

Clinical Outcomes in Patients With Delayed Hospitalization for Non–ST-Segment Elevation Myocardial Infarction - ScienceDirect

The aged cardiovascular risk patient - British Journal of Anaesthesia

Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis - International Journal of Cardiology

On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention - ScienceDirect

fig1.jpg

Residual ST-segment elevation to predict long-term clinical and CMR-derived outcomes in STEMI

©2016-2024, travellemur.com, Inc. or its affiliates